The Immunotype-3 signature was associated with a worse prognosis (borderline significance) in melanoma patients in Mariathasan et al. dataset [36] ( Fig. 6 F ).
← all excerpts
Comprehensive characterization of immune landscape of Indian and Western triple negative breast cancers.
1
—
—